Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So much for the afternoon rally. Very little volume past 10:30.
Apparently the dart hit the same date on the calendar.
The activity into the close will shed some light on how long this will take to chew up sellers, IMO. Still not even close to a heavy volume day. We will see a 100 million share day soon, IMO....and that will move the stock.
Still feel there will be a PR this week, JMHO.
Volume has dried up quickly. After lunch run to close would be nice confirmation that there is a change in price trend. We are 9 days from Abstract release for ASCO.....would also be nice to get another PR prior to.
Digesting the day/trend traders. Would love to see an afternoon run back to HOD. Anyone expecting a PR about ASM? Or was that it do you think?
add my half million to that.
Very little pre-market bid/ask movement. Might be a non-event day.
Abstracts for ASCO released next week? ASM scheduled a month away. Two LL talks, and then ASCO. coming months?
Almost 13,000,000 warrants converted in 2 months? Plus or minus $3 million into the company on top of the loan.
That is the order in which believe things will roll out. Hopefully all within two weeks of each other.
Until we know if there is an abstract or presentation, I don’t think booth size matters. Looks to me that these are placeholders like in the Fall. If they have a journal article, and it was ready to go before ASCO, there is no way they should commit to an ASCO embargo. Maybe topline followed by journal followed by industry theater presentation....
Mixed emotions on the ASM. The fact that there is no request to increase shares and is basically a formality meeting to stay compliant is a little disappointing. It does not create the urgency or foreshadow topline prior as I had hoped. If there were items included such as increasing shares I would believe we need topline first. We could very well get to ASM with no news. I hope I am wrong.
Someone should sent that to DI for clarification. Although he will likely refer you to the Oct 5th PR for info.
Interesting. That's a lot of time and money if you didn't think you would get approval. Also interesting on the pricing. Do you think those the sums Advent gets or NWBO gets?
Had a little pop here, maybe seller is done and we start the slow climb back.
That is the exact same nothing-burger response he has been giving since last October. I asked specifically what I was supposed to read in the Oct 5th PR. No response. All it says is preparing for topline and a journal publication. So, where are we in the process? How long have we bee unblinded? Give us something.
If there was higher volume is be looking for an 8k tonight. Unfortunately i think our PPS is suffering from investor fatigue. The lack of info from the company will have some newer longs become sellers.
Wow, that's all it took? I am worried, and not needlessly. I want an update on where we are. Or, better yet, just PR topline.
I keep doing it to myself but I bought more at $1.30
I guess the obligation is because they said they would publicly. I could care less if they release publicly if they have a plan that goes right to RA approval. I just don't see the downside of providing an update on timing. As cryptic as it will be, at least we would have an idea where we are.
Like FDA Fast track approval? Or, UK? UK could certainly be quicker as we know they have changed endpoints overseas. Wouldn't that be the cart before the horse though? How can you get approval if you haven't released results?
Agreed, I'm not talking about logic. I'm talking about frustrated longs and ambulance chasers. The CYDY lawsuits are frivolous IMO, but still lawsuits that must be defended , and with company resources.
Just hoping we don't get hit with lawsuits like CYDY. Multiple class action suits for false or misleading statements. Luckily NWBO only "falsely" stated topline dates. They never touted positive endpoints or results.
Dec 2018? Oh, is that when they said they were going to start to begin to get ready to put the series of processes in place, that once complete, would begin the multi-month processes (not overlapping), to plan the end of the trial?
I agree with your last two statements which is why I haven't sold either. Just frustrated. Not as much by the time as by the lack of information from the company.
My fear is that some shareholder will go beyond filing with Delaware for an ASM. I am fearful a large investor may take all of their public statements from April to September of 2020 and file a class action lawsuit alleging stock price manipulation. .17 to 2.51 with multiple estimates of topline by certain dates and then going silent for six months with no mention of it. It would be valid IMO due to the wealth the insiders have gained, and potentially viewed as an effort to enrich themselves and raise money at more favorable terms on false promises.
I do not believe they are still blinded. Doesn't mean they won't continue the release of topline. That's all I meant.
Is that the rule? 13 months from previous ASM? We didn't do that from 2019 to 2020. (feb 2019 and then April 2020). I hope you are right that we get the announcement. However, with the lack of info from company, I am terrified they will schedule, ask for shares to survive, and talk about delays from covid, and give no other information.
I sent several simple questions yesterday, including that one and no reply.
This where we are due to mgmt silence. I’m sorry to say but that theory is an enormous reach. I do not believe her book is considered a scientific publication, much less peer-reviewed.
This is where I believe we are (for steps the company outlined):
These processes included:
1. Data validation, DONE. This is what took so long to get to data lock.
2. Analyses of the data by independent statisticians,
preparations by the statisticians of summaries of the Trial results for review by the Company. STATED BY NWBO to be a couple weeks (I'm saying 6) DONE, which means company is unblinded.
Next steps would be concurrent, not one after another, IMO.
3.The Principal Investigator,
3.The Steering Committee of the Trial,
3.The Scientific Advisory Board,
3.A panel of independent brain cancer experts
Much of this is likely done. Opinions and data from these groups contribute to topline PR and Journal publication.
However, since mgmt never tells us anything, who knows how long the final steps of topline PR and Journal will take.
There is absolutely, positively, no freakin way that they are not unblinded. It's been over six months. CRO data compilation estimated at a couple weeks, several times. Given NWBO, and covid, I'd say a couple weeks turned into 6 weeks or so. They have had the data for a while, IMO.
I can't stand reading their PR's or 10K/Q's anymore. In the one you referenced, the new language says: "It is anticipated that public announcement will follow these processes." WTF does that mean? They may not make a public announcement after all of these processes?
We need news, update, topline, something from this awful mgmt group.
6 months and 6 days from Data Lock PR. Zero info on trial results, status or timing. When does the speculation stop and when do we see topline. That is ALL that matters right now.
Like I said this morning, tenuous. Would like to move a over $1.45 for a bit of comfort. Maybe we get a spark from LL's talk today.
I believe Dr. Bala is the only one in.